1. Dos Santos José Carlos, Beijer Barbro, Bauder-Wüst Ulrike*, Schäfer Martin*, Leotta Karin, Eder Matthias*, Benešová Martina*, Kleist Christian, Giesel Frederic, Kratochwil Clemens, Kopka Klaus*, Haberkorn Uwe*, Mier Walter: Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. Journal of nuclear medicine 2020, 61:70-79.

2. Farolfi Andrea*, Ilhan Harun, Gafita Andrei, Calais Jeremie, Barbato Francesco*, Weber Manuel*, Afshar-Oromieh Ali, Spohn Fabian, Wetter Axel, Rischpler Christoph*, Hadaschik Boris, Pianori Davide, Fanti Stefano, Haberkorn Uwe*, Eiber Matthias, Herrmann Ken*, Fendler Wolfgang Peter*: Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET. Journal of nuclear medicine 2020, 61:1037 - 1042.

3. Giannoula E., Panagiotidis E., Katsikavelas I., Chatzipavlidou V., Sachpekidis C.*, Bamidis P., Raftopoulos V., Iakovou I.: Quality & safety aspects of nuclear medicine practice: Definitions and review of the current literature. Hellenic journal of nuclear medicine 2020, 23:60-66.

4. Grossner Tobias, Haberkorn Uwe*, Gotterbarm Tobias: 18F- based Quantification of the Osteogenic Potential of hMSCs. International journal of molecular sciences 2020, 21:7692.

5. Haberkorn Uwe*, Kratochwil Clemens, Giesel Frederik: Internal Radiation Therapy. Recent results in cancer research 2020, 216:881-902.

6. Halama Niels*, Haberkorn Uwe*: The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors. Seminars in nuclear medicine 2020, 50:389-398.

7. Haupt Fabian, Dijkstra Lotte, Alberts Ian, Sachpekidis Christos, Fech Viktor, Boxler Silvan, Gross Tobias, Holland-Letz Tim*, Zacho Helle D, Haberkorn Uwe*, Rahbar Kambiz, Rominger Axel, Afshar-Oromieh Ali: 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol. European Journal of nuclear medicine and molecular imaging 2020, 47:624-631.

8. Heckmann Markus B, Reinhardt Finn, Finke Daniel, Katus Hugo A, Haberkorn Uwe*, Leuschner Florian, Lehmann Lorenz*: Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease. Circulation / Cardiovascular imaging 2020, 13:e010628.

9. Iakovou Ioannis, Giannoula Evanthia, Chatzipavlidou Vasiliki, Sachpekidis Christos*: Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis? Hellenic journal of nuclear medicine 2020, 23:94-95.

10. Iakovou Ioannis, Giannoula Evanthia, Sachpekidis Christos*: Imaging and Imaging-Based Management of Pediatric Thyroid Nodules. Journal of Clinical Medicine 2020, 9:384.

11. Iakovou Ioannis, Symeonidis Panagiotis, Kotrotsios Dimitrios, Giannoula Evanthia, Sachpekidis Christos*: Radiosynoviorthesis after Surgery in the Treatment of Patients with Ankle Pigmented Villonodular Synovitis: A Case Series. Journal of Clinical Medicine 2020, 9:597.

12. Khreish Fadi, Rosar Florian, Kratochwil Clemens, Giesel Frederik Lars, Haberkorn Uwe*, Ezziddin Samer: Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease. European journal of nuclear medicine and molecular imaging 2020, 47:2040-2041.

13. Kim James*, Novak Daniel*, Sachpekidis Christos*, Utikal Jochen*, Larribère Lionel*: STAT3 Relays a Differential Response to Melanoma-Associated NRAS Mutations. Cancers 2020, 12:119.

14. Koerber Stefan A, Stach Gerald, Kratochwil Clemens, Haefner Matthias F, Rathke Henrik, Herfarth Klaus, Kopka Klaus*, Holland-Letz Tim*, Choyke Peter L, Will Leon, Haberkorn Uwe*, Debus Juergen*, Giesel Frederik*: Lymph node involvement in treatment-naïve prostate cancer patients - correlation of PSMA-PET/CT imaging and Roach formula in 280 men in the Radiotherapeutic management. Journal of nuclear medicine 2020, 61:46-50.

15. Koerber Stefan A, Staudinger Fabian, Kratochwil Clemens*, Adeberg Sebastian, Haefner Matthias F, Ungerechts Guy, Rathke Hendrik, Winter Erik, Lindner Thomas, Syed Mustafa, Bhatti Irfan A, Herfarth Klaus, Choyke Peter L, Jaeger Dirk, Haberkorn Uwe*, Debus Juergen*, Giesel Frederik*: The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience. Journal of nuclear medicine 2020, 61:1331 - 1336.

16. Koralli Panagiota*, D. Negka Alkmini*, Vagiaki Lida Evmorfia, Pavlou Aristea, Siskos Michael G., Dimitrakopoulou-Strauss Antonia*, Gregoriou Vasilis G., Chochos Christos L.: New conjugated polymer nanoparticles with high photoluminescence quantum yields for far-red and near infrared fluorescence bioimaging. Materials chemistry frontiers 2020, 4:2357 - 2369.

17. Kratochwil Clemens, Giesel Frederik L, Heussel Claus-Peter, Kazdal Daniel, Endris Volker, Nientiedt Cathleen, Bruchertseifer Frank, Kippenberger Maximilian, Rathke Hendrik, Leichsenring Jonas, Hohenfellner Markus, Morgenstern Alfred, Haberkorn Uwe*, Duensing Stefan, Stenzinger Albrecht: Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes. Journal of nuclear medicine 2020, 61:683 - 688.

18. Kratochwil Clemens, Haberkorn Uwe*, Giesel Frederik Lars: 225Ac-PSMA-617 for Therapy of Prostate Cancer. Seminars in nuclear medicine 2020, 50:133 - 140.

19. Lindner Thomas, Altmann Annette*, Krämer Susanne, Kleist Christian, Loktev Anastasia*, Kratochwil Clemens, Giesel Frederik, Mier Walter, Marme Frederik, Debus Jürgen*, Haberkorn Uwe*: Design and Development of 99m Tc-Labeled FAPI Tracers for SPECT Imaging and 188 Re Therapy. Journal of nuclear medicine 2020, 61:1507 - 1513.

20. Meyer Catherine, Dahlbom Magnus, Lindner Thomas, Vauclin Sebastien, Mona Christine, Slavik Roger, Czernin Johannes*, Haberkorn Uwe*, Calais Jeremie: Radiation Dosimetry and Biodistribution of 68 Ga-FAPI-46 PET Imaging in Cancer Patients. Journal of nuclear medicine 2020, 61:1171 - 1177.

21. Mühlberg Eric, Umstätter Florian, Domhan Cornelius, Hertlein Tobias, Ohlsen Knut, Krause Andreas, Kleist Christian, Beijer Barbro, Zimmermann Stefan, Haberkorn Uwe*, Mier Walter, Uhl Philipp: Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci. Pharmaceuticals 2020, 13:110

22. Nientiedt Cathleen, Endris Volker, Jenzer Maximilian, Mansour Josef, Sedehi Nassim Tawanaie Pour, Pecqueux Carine, Volckmar Anna-Lena, Leichsenring Jonas, Neumann Olaf, Kirchner Martina, Hoveida Shirin, Lantwin Philippa, Kaltenecker Katrin, Dieffenbacher Svenja, Gasch Claudia, Hofer Luisa, Franke Desiree, Tosev Georgi, Görtz Magdalena, Schütz Viktoria, Radtke Jan-Philipp, Nyarangi-Dix Joanne, Hatiboglu Gencay, Simpfendörfer Tobias, Schönberg Gita, Isaac Sanjay, Teber Dogu, Koerber Stefan A, Christofi Georgia, Czink Elena, Kreuter Rebecca, Apostolidis Leonidas, Kratochwil Clemens*, Giesel Frederik*, Haberkorn Uwe*, Debus Jürgen, Sültmann Holger*, Zschäbitz Stefanie, Jäger Dirk, Duensing Anette, Schirmacher Peter, Grüllich Carsten, Hohenfellner Markus, Stenzinger Albrecht, Duensing Stefan: High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel. Urologic oncology 2020, 38:637.e617-637.e627.

23. Petersen Lars J, Nielsen Julie B, Langkilde Niels C, Petersen Astrid, Afshar-Oromieh Ali, De Souza Nandita M, De Paepe Katja, Fisker Rune V, Arp Dennis T, Carl Jesper, Haberkorn Uwe*, Zacho Helle D: 68Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy study. World journal of urology 2020, 38:939-948.

24. Rathke Hendrik, Holland-Letz Tim*, Mier Walter, Flechsig Paul, Mavriopoulou Eleni, Röhrich Manuel, Kopka Klaus*, Hohenfellner Markus, Giesel Frederik L, Haberkorn Uwe A*, Kratochwil Clemens: Response prediction of 177Lu-PSMA-617 RLT using PSA, Chromogranin A, and LDH. Journal of nuclear medicine 2020, 61:689-695.

25. Ristau J.*, Giesel F. L.*, Haefner M. F.*, Staudinger F., Lindner T., Merkel A., Schlittenhardt J., Kratochwil C.*, Choyke P. L., Herfarth K.*, Debus J.*, Haberkorn U.*, Koerber S. A.*: Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer. Molecular imaging & biology 2020, 22:1495-1500.

26. Röhrich Manuel*, Floca Ralf*, Loi Lisa*, Adeberg Sebastian, Windisch Paul, Giesel Frederik L, Kratochwil Clemens, Flechsig Paul, Rathke Hendrik, Lindner Thomas*, Loktev Anastasia*, Schlemmer Heinz Peter*, Haberkorn Uwe*, Paech Daniel*: FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas. European journal of radiology 2020, 127:109021.

27. Röhrich Manuel*, Loi Lisa*, Floca Ralf*, Haberkorn Uwe*, Paech Daniel*: Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients. Data in Brief 2020, 31:105712.

28. Sachpekidis Christos*, Afshar-Oromieh A., Kopka K.*, Strauss D. S.*, Pan Leyun*, Haberkorn U.*, Dimitrakopoulou-Strauss Antonia*: 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer. European journal of nuclear medicine and molecular imaging 2020, 47:592-602.

29. Sachpekidis Christos*, Exadaktylou Paraskevi, Katsampoukas Dimitrios, Moralidis Efstratios, Arsos Georgios: 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine 2020, 23:76-78.

30. Sachpekidis Christos*, Kopp-Schneider Annette*, Merz Maximilian, Jauch Anna, Raab Marc-Steffen, Goldschmidt Hartmut, Dimitrakopoulou-Strauss Antonia*: Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? Cancers 2020, 12:1335.

31. Sachpekidis Christos*, Sidiropoulou Polytimi, Hassel Jessica C, Drakoulis Nikolaos, Dimitrakopoulou-Strauss Antonia*: Positron Emission Tomography in Merkel Cell Carcinoma. Cancers 2020, 12:2897.

32. Salzmann Martin, Benesova Karolina, Buder-Bakhaya Kristina, Papamichail Dimitrios*, Dimitrakopoulou-Strauss Antonia*, Lorenz Hanns-Martin, Enk Alexander H, Hassel Jessica C: Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients. Cancers 2020, 12:3004.

33. Sauter Max, Strieker Matthias, Kleist Christian, Wischnjow Artjom, Daniel Volker, Altmann Annette*, Haberkorn Uwe*, Mier Walter: Improving antibody-based-therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery. Journal of controlled release 2020, 322:200-208.

34. Schaefer Anne, Sachpekidis Christos*, Diella Francesca, Doerks Anja, Kratz Anne-Sophie, Meisel Christian, Jackson David B, Soldatos Theodoros G: Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients. Cancers 2020, 12:1008.

35. Scherer Jonas*, Nolden Marco*, Kleesiek Jens*, Metzger Jasmin*, Kades Klaus*, Schneider Verena*, Bach Michael*, Sedlaczek Oliver*, Bucher Andreas M*, Vogl Thomas J*, Grünwald Frank*, Kühn Jens-Peter*, Hoffmann Ralf-Thorsten*, Kotzerke Jörg*, Bethge Oliver*, Schimmöller Lars*, Antoch Gerald*, Müller Hans-Wilhelm*, Daul Andreas*, Nikolaou Konstantin*, la Fougère Christian*, Kunz Wolfgang G*, Ingrisch Michael*, Schachtner Balthasar*, Ricke Jens*, Bartenstein Peter*, Nensa Felix*, Radbruch Alexander*, Umutlu Lale*, Forsting Michael*, Seifert Robert*, Herrmann Ken*, Mayer Philipp*, Kauczor Hans-Ulrich*, Penzkofer Tobias*, Hamm Bernd*, Brenner Winfried*, Kloeckner Roman*, Düber Christoph*, Schreckenberger Mathias*, Braren Rickmer*, Kaissis Georgios*, Makowski Marcus*, Eiber Matthias*, Gafita Andrei*, Trager Rupert*, Weber Wolfgang A*, Neubauer Jakob*, Reisert Marco*, Bock Michael*, Bamberg Fabian*, Hennig Jürgen*, Meyer Philipp Tobias*, Ruf Juri*, Haberkorn Uwe*, Schoenberg Stefan O*, Kuder Tristan Anselm*, Neher Peter*, Floca Ralf Omar*, Schlemmer Heinz-Peter*, Maier-Hein Klaus*: Joint Imaging Platform for Federated Clinical Data Analytics. JCO clinical cancer informatics 2020, 4:1027 - 1038.

36. Shinya Takayoshi, Otomi Yoichi, Dimitrakopoulou-Strauss Antonia*, Kubo Michiko, Kondo Mihoko, Otomo Maki, Terazawa Kaori, Bando Yoshimi, Harada Masafumi: Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study. Nuclear medicine communications 2020, 41:26 - 33.

37. Syed M., Flechsig P., Liermann J., Windisch P., Staudinger F., Akbaba S., Koerber S. A., Freudlsperger C., Plinkert P. K., Debus J.*, Giesel F., Haberkorn U.*, Adeberg S.: Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers. European journal of nuclear medicine and molecular imaging 2020, 47:2836-2845.

38. Umstätter Florian, Domhan Cornelius, Hertlein Tobias, Ohlsen Knut, Mühlberg Eric, Kleist Christian, Zimmermann Stefan, Beijer Barbro, Klika Karel D*, Haberkorn Uwe*, Mier Walter, Uhl Philipp: Vancomycin Resistance is Overcome by Conjugation of Polycationic Peptides. Angewandte Chemie / International edition International edition 2020, 59:8823-8827.

39. Windisch Paul, Röhrich Manuel, Regnery Sebastian, Tonndorf-Martini Eric, Held Thomas, Lang Kristin, Bernhardt Denise, Rieken Stefan, Giesel Frederik, Haberkorn Uwe*, Debus Jürgen*, Adeberg Sebastian*: Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma. Radiotherapy and oncology 2020, 150:159 - 163.

40. Windisch Paul, Zwahlen Daniel R, Koerber Stefan A*, Giesel Frederik L, Debus Jürgen*, Haberkorn Uwe*, Adeberg Sebastian*: Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review. Cancers 2020, 12:2629.

41. Zippel Claus, Ronski Sarah C, Bohnet-Joschko Sabine, Giesel Frederik L*, Kopka Klaus*: Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on Pharmaceuticals 2020, 13:12.

nach oben
powered by webEdition CMS